| Members |
targetComponentId |
| Class Scotobacteria |
Class Betaproteobacteria (organism) |
| Class Scotobacteria |
Class Alphaproteobacteria (organism) |
| Class in general exercises |
Class in physical fitness and conditioning |
| Class in general exercises |
Exercise class |
| Classic apraxia |
Transcortical apraxia |
| Classic apraxia |
Classic apraxia |
| Classic apraxia |
Limb-kinetic apraxia |
| Classical galactosemia |
Deficiency of UTP-hexose-1-phosphate uridylyltransferase |
| Classical-complement-pathway C3/C5 convertase |
Active C4b2a |
| Classical-complement-pathway C3/C5 convertase |
Active C4b2a3b |
| Claudication (& [intermittent]) |
Intermittent claudication |
| Cleans |
Cleans drug injection equipment |
| rengör kanyler med blekmedel |
Cleans drug injection needle with bleach (finding) |
| Clear |
Clear |
| Clear |
Translucent |
| klarcelligt karcinom i lunga |
Primary clear cell adenocarcinoma of lung |
| Clear cell tumor of ovary |
Clear cell adenocarcinoma of ovary (disorder) |
| Clearance of airway (& aspiration bronchus NEC) |
Airway toilet |
| ansiktsspalt |
Craniofacial cleft (disorder) |
| Cleft hard palate, unilateral |
Cleft of left hard palate |
| Cleft hard palate, unilateral |
Cleft of right hard palate (disorder) |
| Cleft palate NOS: [complete] or [hard] |
Cleft palate |
| Cleft palate NOS: [complete] or [hard] |
Cleft hard and soft palate |
| Cleft palate NOS: [incomplete] or [soft) |
Cleft of soft palate (disorder) |
| Cleft palate NOS: [incomplete] or [soft) |
Cleft palate |
| kleidotomi |
Fetal clavicotomy |
| intelligent |
Above average intellect |
| Clicking hip (& congenital) |
Clicking hip |
| klimakterisk artrit i underarm |
Climacteric arthritis |
| klimakterisk artrit i underben |
Climacteric arthritis |
| klimakterisk artrit i överarm |
Climacteric arthritis of the shoulder region |
| Clindamycin 1% gel |
Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) |
| klindamycin 1 %, roll-onlotion |
Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous lotion |
| klindamycin 1 %, alkohollösning för lokalt bruk |
Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution |
| klindamycin 300 mg/2 ml, för injektion |
Product containing precisely clindamycin (as clindamycin phosphate) 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| klindamycin 600 mg/4 ml, för injektion |
Product containing precisely clindamycin (as clindamycin phosphate) 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Clindamycin [skin] |
Product containing clindamycin in cutaneous dose form (medicinal product form) |
| Clindamycin and lincomycin |
Product containing clindamycin (medicinal product) |
| Clindamycin and lincomycin |
Product containing lincomycin (medicinal product) |
| Clindamycin phosphate 150mg/mL injection solution 4mL ampule |
Product containing precisely clindamycin (as clindamycin phosphate) 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Clindamycin phosphate 300mg/2mL injection |
Product containing precisely clindamycin (as clindamycin phosphate) 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Clindamycin phosphate 300mg/2mL injection solution 2mL vial |
Product containing precisely clindamycin (as clindamycin phosphate) 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Clindamycin phosphate 600mg/4mL injection |
Product containing precisely clindamycin (as clindamycin phosphate) 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Clinical conference |
Team conference (procedure) |
| Clinical conference |
Telephone consultation (procedure) |
| klinisk anamnes och observationsfynd |
Clinical finding (finding) |
| klinisk farmakologisk vård |
Clinical pharmacology service (qualifier value) |
| klinisk fysiologisk vård |
Clinical physiology service |
| Clinical psychiatric mental status determination |
Assessment of mental status by psychiatrist (procedure) |
| Clinical psychiatric mental status determination |
Neurological mental status determination (procedure) |
| Clinical psychologic mental status determination |
Assessment of mental status by psychiatrist (procedure) |
| Clinical psychologic mental status determination |
Neurological mental status determination (procedure) |
| tillämpning av klinisk röntgen |
Radiographic imaging procedure |
| tillämpning av klinisk röntgen |
Radiographic imaging procedure with explicit context (situation) |
| Clinical radiology application |
Radiographic imaging procedure |
| Clinical radiology application |
Radiographic imaging procedure with explicit context (situation) |
| Clipping aneurysm (& intracerebral) |
Aneurysm clipping (procedure) |
| Clipping aneurysm (& intracerebral) |
Aneurysm clipping (procedure) |
| Clipping aneurysm (& intracerebral) |
Application of clamp to cerebral aneurysm, Crutchfield or Silverstone |
| Clipping aneurysm (& intracerebral) |
Application of clamp to cerebral aneurysm, Crutchfield or Silverstone |
| Clitoridectomy |
Clitoridectomy |
| Clitoridectomy |
Simple clitoridectomy |
| Clitoris: [other congenital anomaly] or [hooded] or [hypertrophy] |
Hooded clitoris |
| klobetasolpropionat 0,05 %, mjukgörande kräm |
Clobetasol propionate 500 microgram/mL cutaneous cream |
| preparat med klobetasolpropionat för lokalt bruk |
Product containing clobetasol in cutaneous dose form (medicinal product form) |
| klobetasolprpionat + neomycinsulfat +nystatin |
Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) |
| Clofibrate group adverse reaction |
Clofibrate adverse reaction |
| Clofibrate group allergy |
Allergy to clofibrate (finding) |
| klomipraminhydroklorid 12,5 mg/ml, injektionsvätska, lösning, ampull 2 ml |
Product containing precisely clomipramine hydrochloride 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| klomipraminhydroklorid 75 mg, tablett med modifierad frisättning |
Product containing precisely clomipramine hydrochloride 75 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Clonal protein disease |
Monoclonal gammopathy (clinical) |
| Clonal protein disease |
Disorder of increased production of immunoglobulin protein (disorder) |
| klonazepam 0,5 mg/5 ml, sockerfri lösning för oralt bruk |
Product containing precisely clonazepam 100 microgram/1 milliliter conventional release oral solution (clinical drug) |
| klonazepam 2 mg/5 ml, sockerfri lösning för oralt bruk |
Product containing precisely clonazepam 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
| Clonidine hydrochloride |
Product containing clonidine (medicinal product) |
| klonidinhydroklorid 150 mikrogram/ml, injektionsvätska, lösning, ampull 1 ml |
Product containing precisely clonidine hydrochloride 150 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| klonidinhydroklorid 250 mikrogram, kapsel med modifierad frisättning |
Product containing precisely clonidine hydrochloride 250 microgram/1 each prolonged-release oral capsule (clinical drug) |
| Clonidine m/r |
Product containing precisely clonidine hydrochloride 250 microgram/1 each prolonged-release oral capsule (clinical drug) |
| Clopenthixol |
Product containing zuclopenthixol (medicinal product) |
| Clopenthixol |
Product containing clopenthixol (medicinal product) |
| Clopixol Acuphase 100mg/2mL oily injection |
Product containing precisely zuclopenthixol acetate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Clopixol Acuphase 50mg/1mL oily injection |
Product containing precisely zuclopenthixol acetate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Closed (or no) reduction of fracture and external fixation |
Closed reduction of fracture and external fixation (procedure) |
| Closed (or no) reduction of fracture and external fixation |
Open reduction of fracture and external fixation (procedure) |
| Closed (or no) reduction of fracture and internal fixation |
Closed reduction of rib fracture with external fixation |
| Closed (or no) reduction of fracture and internal fixation |
Open reduction of fracture with internal fixation |
| Closed atrial septectomy |
Closed atrial septectomy |
| Closed atrial septectomy |
Blalock Hanlon operation |
| sluten skada orsakad av trubbigt våld |
Wound, closed |
| sluten cerebral kontusion |
Cortex contusion without open intracranial wound |
| sluten cerebral kontusion |
Contusion of cerebrum |
| Closed dislocation of thoracic and lumbar spine not otherwise specified |
Closed dislocation of thoracic and lumbar spine |
| sluten luxation i bröst- och/eller ländryggrad |
Fracture dislocation of lumbosacral junction |
| sluten luxation i bröst- och/eller ländryggrad |
Closed dislocation of thoracic and lumbar spine |
| Closed dislocation: [C2/C3] or [third cervical vertebra (C3)] |
Closed dislocation C2/C3 |
| Closed dislocation: [C3/C4] or [fourth cervical vertebra (C4)] |
Closed dislocation C3/C4 |
| Closed dislocation: [C4/C5] or [fifth cervical vertebra (C5)] |
Closed dislocation C4/C5 |
| Closed dislocation: [C5/C6] or [sixth cervical vertebra (C6)] |
Closed dislocation C5/C6 |
| Closed dislocation: [C6/C7] or [seventh cervical vertebra (C7)] |
Closed dislocation C6/C7 |
| Closed dislocation: [atlanto-axial joint] or [second cervical vertebra (C2)] |
Closed dislocation atlantoaxial joint |
| Closed dislocation: [atlanto-occipital joint] or [atlanto-axial joint] or [first cervical vertebra (C1)] |
Closed dislocation atlanto-occipital joint |
FHIR